全文获取类型
收费全文 | 8127篇 |
免费 | 533篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 278篇 |
妇产科学 | 176篇 |
基础医学 | 979篇 |
口腔科学 | 261篇 |
临床医学 | 798篇 |
内科学 | 1632篇 |
皮肤病学 | 96篇 |
神经病学 | 810篇 |
特种医学 | 463篇 |
外国民族医学 | 1篇 |
外科学 | 1064篇 |
综合类 | 114篇 |
一般理论 | 2篇 |
预防医学 | 791篇 |
眼科学 | 129篇 |
药学 | 529篇 |
中国医学 | 3篇 |
肿瘤学 | 434篇 |
出版年
2021年 | 88篇 |
2020年 | 59篇 |
2019年 | 112篇 |
2018年 | 136篇 |
2017年 | 94篇 |
2016年 | 117篇 |
2015年 | 135篇 |
2014年 | 156篇 |
2013年 | 279篇 |
2012年 | 394篇 |
2011年 | 409篇 |
2010年 | 247篇 |
2009年 | 233篇 |
2008年 | 363篇 |
2007年 | 361篇 |
2006年 | 369篇 |
2005年 | 376篇 |
2004年 | 302篇 |
2003年 | 285篇 |
2002年 | 275篇 |
2001年 | 283篇 |
2000年 | 282篇 |
1999年 | 198篇 |
1998年 | 83篇 |
1997年 | 78篇 |
1996年 | 77篇 |
1995年 | 53篇 |
1994年 | 70篇 |
1993年 | 74篇 |
1992年 | 151篇 |
1991年 | 158篇 |
1990年 | 169篇 |
1989年 | 159篇 |
1988年 | 128篇 |
1987年 | 147篇 |
1986年 | 130篇 |
1985年 | 172篇 |
1984年 | 111篇 |
1983年 | 108篇 |
1982年 | 55篇 |
1981年 | 67篇 |
1980年 | 63篇 |
1979年 | 106篇 |
1978年 | 72篇 |
1977年 | 58篇 |
1975年 | 56篇 |
1974年 | 60篇 |
1973年 | 56篇 |
1972年 | 54篇 |
1970年 | 53篇 |
排序方式: 共有8677条查询结果,搜索用时 11 毫秒
51.
C N Coleman L Noll A E Howes J R Harris J Zakar R A Kramer 《International journal of radiation oncology, biology, physics》1989,16(4):1085-1087
To exploit both the oxygen-mimetic and "pre-incubation" or continuous exposure effects of the 2-nitroimidazole radiosensitizers, we are conducting a Phase I trial of continuous infusion SR 2508 for patients receiving brachytherapy. Following the administration of a loading dose of 2 g/m2, SR 2508 is administered by continuous infusion for 48 hr. Twenty-one patients have completed treatment. The initial total dose was 8 g/m2 with patients currently receiving 15 g/m2. No toxicity has been observed. At the higher doses the steady-state plasma concentrations have been between 50 and 70 micrograms/ml. It is not yet known whether or not hypoxic sensitizers will be of benefit clinically, and if so, when during a course of treatment is the optimal time to use them. Given the lack of toxicity and plasma concentrations achievable with continuous infusion, future studies will be conducted using SR 2508 during both the external beam and brachytherapy aspects of treatment. 相似文献
52.
Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer 总被引:6,自引:0,他引:6
Scholten KB Schreurs MW Ruizendaal JJ Kueter EW Kramer D Veenbergen S Meijer CJ Hooijberg E 《Clinical immunology (Orlando, Fla.)》2005,114(2):119-129
Human papilloma virus (HPV) type 16 infections of the genital tract are associated with the development of cervical cancer (CxCa) in women. HPV16-derived oncoproteins E6 and E7 are expressed constitutively in these lesions and might therefore be attractive candidates for T-cell-mediated adoptive immunotherapy. However, the low precursor frequency of HPV16E7-specific T cells in patients and healthy donors hampers routine isolation of these cells for adoptive transfer. To overcome this problem, we have isolated T cell receptor (TCR) genes from four different HPV16E7-specific healthy donor and patient-derived human cytotoxic T lymphocyte (CTL) clones. We examined whether genetic engineering of peripheral blood-derived CD8+ T cells in order to express HPV16E711-20-specific TCRs is feasible for adoptive transfer purposes. Reporter cells (Jurkat/MA) carrying a transgenic TCR were shown to bind relevant but not irrelevant tetramers. Moreover, these TCR-transgenic Jurkat/MA cells showed reactivity towards relevant target cells, indicating proper functional activity of the TCRs isolated from already available T cell clones. We next introduced an HPV16E711-20-specific TCR into blood-derived, CD8+ recipient T cells. Transgenic CTL clones stained positive for tetramers presenting the relevant HPV16E711-20 epitope and biological activity of the TCR in transduced CTL was confirmed by lytic activity and by interferon (IFN)-gamma secretion upon antigen-specific stimulation. Importantly, we show recognition of the endogenously processed and HLA-A2 presented HPV16E711-20 CTL epitope by A9-TCR-transgenic T cells. Collectively, our data indicate that HPV16E7 TCR gene transfer is feasible as an alternative strategy to generate human HPV16E7-specific T cells for the treatment of patients suffering from cervical cancer and other HPV16-induced malignancies. 相似文献
53.
Füst G Arason GJ Kramer J Szalai C Duba J Yang Y Chung EK Zhou B Blanchong CA Lokki ML Bödvarsson S Prohászka Z Karádi I Vatay A Kovács M Romics L Thorgeirsson G Yu CY 《International immunology》2004,16(10):1507-1514
The genetic basis for addiction to tobacco smoking--particularly that of the perception of olfactory stimuli that may be important in reinforcing smoking addiction--is largely unknown. A cluster of genes for olfactory receptors is in close proximity to the MHC region on chromosome 6. Polymorphisms of MHC class III genes (RCCX modules, TNFA promoter polymorphisms) were determined in 101 healthy subjects and 232 coronary artery disease (CAD) patients from Hungary with defined tobacco smoking habits. A highly significant association between ever smoking (past + current smokers) and a specific MHC haplotype was observed (odds ratios = 2.14-4.13; P-values = 0.012 to <0.001). This haplotype is characterized by the presence of C4A null alleles and a solitary short C4B gene linked to the TNF2 allele of the promoter for TNFA gene. This haplotype occurred more frequently in the ever smokers than in the never smokers [odds ratio: 4.97 (1.96-12.62); P = 0.001], and such associations were stronger in women (odds ratio = 13.6) than in men (odds ratio = 2.79). An independent study of complement C4 protein polymorphism and smoking habits in Icelandic subjects (n = 351) yielded similar and confirmative results. Considering the documented link between olfactory stimuli and smoking in females, and the presence of a cluster of odorant receptor genes close to the MHC class I region, our findings implicate a potential role of the MHC-linked olfactory receptor genes in the initiation of smoking. 相似文献
54.
John S Thompson Claire Pomeroy Richard J Kryscio Stephen A Brown Donna Reece Rita Kramer Dianna S Howard Gary VanZant Suzanne Humphries Gordon Phillips 《Biology of blood and marrow transplantation》2004,10(12):858-866
To reduce the toxicity of traditional conditioning regimens for allogeneic stem cell transplantation (allo-SCT), we used single-agent chemotherapy conditioning with either busulfan (total cumulative dose, 16 mg/kg) or melphalan (200 to 240 mg/m 2 ), followed by the anti-T cell-specific monoclonal antibody T10B9 (MEDI-500) daily for 3 days. T cell-replete SCT was performed from HLA-identical sibling donors. Acute graft-versus-host disease (aGVHD) prophylaxis consisted of 7 additional days of T10B9 and delayed onset of cyclosporine (ie, on day +4 or +5). Twenty-six high-risk hematologic malignancy patients were entered onto this study. All 24 patients who survived longer than 8 days engrafted, although 1 patient experienced late graft failure. Deaths occurred in 21 of 26 patients because of infection (n = 7), progression/recurrence of primary disease (n = 6), aGVHD (n = 4), regimen-related toxicity (n = 1), and other causes (n = 3). Five of these patients are enjoying disease-free survival with a median survival of 1193 days after allo-SCT. The conditioning regimen induced modulation of surface expression of CD3 (but not CD4 or CD8) and was associated with decreasing tumor necrosis factor-alpha (but not interleukin-6) serum levels. In conclusion, single-agent chemotherapy conditioning with T10B9 produced durable engraftment and long-term survival in some patients who would not have qualified for a traditional allo-SCT. 相似文献
55.
Yves de Roten Mlanie Fischer Martin Drapeau Vronique Beretta Ueli Kramer Nathalie Favre Jean‐Nicolas Despland 《Clinical psychology & psychotherapy》2004,11(5):324-331
Early therapeutic alliance is usually measured by the rating of a single session (between the third and the fifth sessions). However, there is a strong argument in favor of viewing early alliance as a developing process. This study examined the relationship between patient's rating of the helping alliance (HAq) at each session and therapy outcome. This comparison was repeated using patterns of alliance over the course of treatment. Patterns of therapeutic alliance development were detected by clustering ratings of a sample of N = 70 outpatients across four sessions of very brief psychotherapeutic intervention. Cluster analysis revealed two main patterns (shapes) of alliance development: (i) stable alliance, and (ii) linear growth pattern. These patterns are more predictive of symptom improvement and social adjustment than single ratings, whereas single ratings measuring the strength of alliance are more correlated with patient's satisfaction. Copyright © 2004 John Wiley & Sons, Ltd. 相似文献
56.
57.
Respiratory distress syndrome in second-born versus first-born twins. A matched case-control analysis 总被引:2,自引:0,他引:2
C Arnold F H McLean M S Kramer R H Usher 《The New England journal of medicine》1987,317(18):1121-1125
The well-known increased risk of the respiratory distress syndrome in a twin born second as compared with the twin born first is usually attributed to the second twin's predisposition to depression at birth ("asphyxia"). We analyzed the etiologic roles of birth order, presentation, and depression at birth in the development of the respiratory distress syndrome in matched case-control populations drawn from 221 preterm twin pairs. Among the 39 twin pairs discordant for respiratory distress syndrome, the second twin was the affected member in 31 pairs. Second birth order was the only independent risk factor, but only in vaginal deliveries (matched odds ratio, 14.2; 95 percent confidence interval, 2.5 to 81.1). Second twins delivered abdominally did not have an increased risk relative to first twins (odds ratio, 0.9; confidence interval, 0 to 17.8). When depression at birth was evaluated as an outcome variable, malpresentation, rather than birth order, was the major risk factor (independent matched odds ratios of 2.7 [confidence interval, 1.0 to 7.5] and 1.3 [0.7 to 2.5], respectively). Thus, second twins' increased risk of respiratory distress syndrome cannot be explained by a predisposition to depression at birth; a more important factor may be that second twins do not benefit from the salutary effects of labor to the same extent as first twins. 相似文献
58.
59.
Bank I Tick LW Hutten BA Kramer MH Middeldorp S Büller HR 《Pathophysiology of haemostasis and thrombosis》2003,33(4):192-196
Acquired and inherited thrombophilic factors increase the risk for (recurrent) venous thrombotic disease. However, little is known about the pathophysiological mechanisms causing these recurrences, or the persistence of thrombosis despite adequate treatment. Because residual thrombosis has been associated with a worse prognostic outcome, we performed an explorative study in order to investigate the prevalence of residual thrombotic lesions after anticoagulant treatment in patients with deep venous thrombosis. Thrombotic parameters as assessed by ultrasonography after a 12-week course of anticoagulants were used. Both thrombophilia in general and acquired thrombophilia in particular were found to be associated with the extent of residual thrombosis. Of the individual thrombophilic factors, protein C deficiency, prothrombin 20210A mutation, active malignant disease and lupus anticoagulant were associated with an increased risk of residual thrombotic mass. Patients with inherited thrombophilia did not differ from patients without any thrombophilic abnormality with regard to residual thrombotic mass [relative risk (RR) 1.3, 95% confidence interval (CI) 0.9-1.8], while acquired thrombophilic disorders increased the risk for residual thrombotic mass as compared to patients without any defect (RR 1.7, 95% CI 1.2-2.2). Although these results should be confirmed in a larger study, they might help us form hypotheses concerning why patients with thrombophilia are more prone to recurrent venous thromboembolic disease. 相似文献
60.
Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. 总被引:3,自引:4,他引:3
W A Siddiqui L Q Tam S C Kan K J Kramer S E Case K L Palmer K M Yamaga G S Hui 《Infection and immunity》1986,52(1):314-318
Monoclonal antibodies to the major Plasmodium falciparum merozoite surface coat and rhoptry antigens were produced. A combination of the affinity-purified polypeptides with Freund complete adjuvant which was given three times completely protected an Aotus lemurinus azure (karotype VI) monkey against homologous challenge; however, immunization with the same polypeptides with a muramyl dipeptide derivative [MDP-Lys(L18)] did not protect a second Aotus monkey, even though comparable high antibody titers were induced. 相似文献